Study of Efficacy and Safety of MIJ821 in Addition to Comprehensive Standard of Care on the Rapid Reduction of Symptoms of Major Depressive Disorder in Subjects Who Have Suicidal Ideation With Intent
Clinical trial NCT04722666 · TERMINATED
Trial details
- NCT number
- NCT04722666
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-20
- Primary completion
- 2023-09-26
- Enrollment
- 199
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.